Heron Therapeutics, Inc. (HRTX)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
As of 02:57PM EST. Market open.
| Previous close | 1.2300 |
| Open | 1.2300 |
| Bid | 1.3000 x 1300 |
| Ask | 1.3100 x 3100 |
| Day's range | 1.1600 - 1.3200 |
| 52-week range | 0.5000 - 3.4100 |
| Volume | |
| Avg. volume | 2,896,424 |
| Market cap | 192.844M |
| Beta (5Y monthly) | 1.12 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.8800 |
| Earnings date | 14 Nov 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 6.50 |
Simply Wall St.CEO & Director of Heron Therapeutics Craig Collard Buys 411% More Shares
Investors who take an interest in Heron Therapeutics, Inc. ( NASDAQ:HRTX ) should definitely note that the CEO...
Insider MonkeyHeron Therapeutics, Inc. (NASDAQ:HRTX) Q3 2023 Earnings Call Transcript
Heron Therapeutics, Inc. (NASDAQ:HRTX) Q3 2023 Earnings Call Transcript November 14, 2023 Heron Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.17, expectations were $-0.31. Operator: Good day, ladies and gentlemen, and thank you for standing by. Welcome to the Heron Therapeutics Q3 2023 Earnings Conference Call. As a reminder, this conference is being recorded. […]
- Thomson Reuters StreetEvents
Q3 2023 Heron Therapeutics Inc Earnings Call
Q3 2023 Heron Therapeutics Inc Earnings Call
© 2023 Yahoo. All rights reserved.